DK2609194T3 - Fremgangsmåder til berigelse af pluripotente stamcelle-afledte kardiomyocyt-progenitorceller og kardiomyocytceller baseret på SIRPA-ekspression - Google Patents

Fremgangsmåder til berigelse af pluripotente stamcelle-afledte kardiomyocyt-progenitorceller og kardiomyocytceller baseret på SIRPA-ekspression Download PDF

Info

Publication number
DK2609194T3
DK2609194T3 DK11819236.8T DK11819236T DK2609194T3 DK 2609194 T3 DK2609194 T3 DK 2609194T3 DK 11819236 T DK11819236 T DK 11819236T DK 2609194 T3 DK2609194 T3 DK 2609194T3
Authority
DK
Denmark
Prior art keywords
cardiomyocyte
methods
stem cell
pluripotent stem
cells
Prior art date
Application number
DK11819236.8T
Other languages
English (en)
Inventor
Gordon Keller
Nicole C Dubois
April M Craft
Original Assignee
Univ Health Network
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Health Network filed Critical Univ Health Network
Application granted granted Critical
Publication of DK2609194T3 publication Critical patent/DK2609194T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0657—Cardiomyocytes; Heart cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6881—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for tissue or cell typing, e.g. human leukocyte antigen [HLA] probes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/115—Basic fibroblast growth factor (bFGF, FGF-2)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/155—Bone morphogenic proteins [BMP]; Osteogenins; Osteogenic factor; Bone inducing factor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/16—Activin; Inhibin; Mullerian inhibiting substance
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/165—Vascular endothelial growth factor [VEGF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/40—Regulators of development
    • C12N2501/415—Wnt; Frizzeled
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/02—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from embryonic cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/45—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from artificially induced pluripotent stem cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5073—Stem cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Cardiology (AREA)
  • Rheumatology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
DK11819236.8T 2010-08-27 2011-08-26 Fremgangsmåder til berigelse af pluripotente stamcelle-afledte kardiomyocyt-progenitorceller og kardiomyocytceller baseret på SIRPA-ekspression DK2609194T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US37766510P 2010-08-27 2010-08-27
PCT/CA2011/000965 WO2012024782A1 (en) 2010-08-27 2011-08-26 Methods for enriching pluripotent stem cell-derived cardiomyocyte progenitor cells and cardiomyocyte cells based on sirpa expression

Publications (1)

Publication Number Publication Date
DK2609194T3 true DK2609194T3 (da) 2019-05-06

Family

ID=45722784

Family Applications (1)

Application Number Title Priority Date Filing Date
DK11819236.8T DK2609194T3 (da) 2010-08-27 2011-08-26 Fremgangsmåder til berigelse af pluripotente stamcelle-afledte kardiomyocyt-progenitorceller og kardiomyocytceller baseret på SIRPA-ekspression

Country Status (10)

Country Link
US (3) US9994821B2 (da)
EP (1) EP2609194B1 (da)
JP (4) JP6199740B2 (da)
CN (1) CN103189502A (da)
AU (1) AU2011293052A1 (da)
CA (1) CA2809498C (da)
DK (1) DK2609194T3 (da)
ES (1) ES2724198T3 (da)
SG (2) SG10201603901UA (da)
WO (1) WO2012024782A1 (da)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2829804A1 (en) * 2011-03-29 2012-10-04 Geron Corporation Enriched populations of cardiomyocyte lineage cells from pluripotent stem cells
WO2012162741A1 (en) * 2011-06-01 2012-12-06 Monash University Enrichment of cardiomyocytes
JP6373253B2 (ja) * 2012-07-17 2018-08-15 国立大学法人京都大学 新規心筋細胞マーカー
US9822342B2 (en) 2013-05-14 2017-11-21 Kyoto University Method of efficiently inducing cardiomyocytes
SG11201601922PA (en) * 2013-09-13 2016-04-28 Univ Health Network Methods and compositions for generating epicardium cells
EP3097186B1 (en) * 2014-01-21 2019-05-08 The Medical College of Wisconsin, Inc. Methods for selective inhibition of pluripotent stem cells
US10144916B2 (en) * 2014-05-09 2018-12-04 Becton, Dickinson And Company Cell surface signature for processing cardiomyocyte subsets from heterogeneous cell samples
JP2016067243A (ja) * 2014-09-29 2016-05-09 国立大学法人鳥取大学 多能性幹細胞由来心筋細胞の取得方法
WO2016127259A1 (en) 2015-02-11 2016-08-18 The Hospital For Sick Children Alveolar-like macrophages and method of generating same
US10561687B2 (en) 2015-02-17 2020-02-18 University Health Network Methods for making and using sinoatrial node-like pacemaker cardiomyocytes and ventricular-like cardiomyocytes
JP2017108705A (ja) * 2015-12-18 2017-06-22 国立大学法人京都大学 心筋細胞の製造方法
ES2897945T3 (es) 2016-06-01 2022-03-03 Miltenyi Biotec Bv & Co Kg Procedimiento de generación, identificación y aislamiento de cardiomiocitos derivados de células madre pluripotentes humanas y subpopulaciones de cardiomiocitos
JOP20190009A1 (ar) 2016-09-21 2019-01-27 Alx Oncology Inc أجسام مضادة ضد بروتين ألفا منظم للإشارات وطرق استخدامها
WO2018062269A1 (ja) * 2016-09-30 2018-04-05 京都府公立大学法人 体細胞を製造する方法、体細胞、及び組成物
RU2019120696A (ru) * 2016-12-04 2021-01-11 Юниверсити Хелт Нетворк Получение линий кардиомиоцитов предсердий и желудочков из плюрипотентных стволовых клеток человека
US10386368B2 (en) 2017-02-24 2019-08-20 Trustees Of Boston University Isolation of human lung progenitors derived from pluripotent stem cells
CA3071193A1 (en) 2017-07-26 2019-01-31 Forty Seven, Inc. Anti-sirp-alpha antibodies and related methods
US20200246389A1 (en) * 2017-09-22 2020-08-06 University Of Miami Methods for obtaining cardiomyogenic precursor cells
WO2019183266A1 (en) 2018-03-21 2019-09-26 ALX Oncology Inc. Antibodies against signal-regulatory protein alpha and methods of use
US11555179B2 (en) 2019-02-01 2023-01-17 The University Of Hong Kong Identification of subpopulations of cardiomyocytes

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ517002A (en) * 1999-08-05 2004-06-25 Mcl Llc Multipotent adult stem cells and methods for isolation
JP3909986B2 (ja) * 1999-08-09 2007-04-25 花王株式会社 パルプモールド成形体
CA2395950A1 (en) 1999-12-28 2001-07-05 Kyowa Hakko Kogyo Co., Ltd. Cells capable of differentiating into heart muscle cells
US7732199B2 (en) * 2001-07-12 2010-06-08 Geron Corporation Process for making transplantable cardiomyocytes from human embryonic stem cells
US20030232430A1 (en) 2001-11-26 2003-12-18 Advanced Cell Technology Methods for making and using reprogrammed human somatic cell nuclei and autologous and isogenic human stem cells
DE10242338A1 (de) 2002-09-09 2004-03-18 Eberhard-Karls-Universität Tübingen Universitätsklinikum Antikörper zur Isolierung und/oder Identifizierung mesenchymaler Stammzellen und Verfahren zur Isolierung und/oder Identifizierung mesenchymaler Stammzellen
WO2005090558A1 (en) 2004-03-19 2005-09-29 Geron Corporation Method for making high purity cardiomyocyte preparations suitable for regenerative medicine
CN101020081A (zh) * 2007-03-16 2007-08-22 重庆大学 一种用于梗死心肌修复与血管重建的细胞移植组合物
AU2007357127B2 (en) * 2007-07-31 2014-06-26 Es Cell International Pte Ltd Method for identifying and selecting cardiomyocytes
EP2498797A4 (en) * 2009-11-09 2013-12-25 Brigham & Womens Hospital TREATMENT OF CARDIOPATHY
WO2012162741A1 (en) * 2011-06-01 2012-12-06 Monash University Enrichment of cardiomyocytes

Also Published As

Publication number Publication date
US20200239848A1 (en) 2020-07-30
CA2809498A1 (en) 2012-03-01
CN103189502A (zh) 2013-07-03
US20190322986A1 (en) 2019-10-24
CA2809498C (en) 2020-03-31
JP2017038623A (ja) 2017-02-23
JP6199740B2 (ja) 2017-09-20
JP2018201522A (ja) 2018-12-27
EP2609194B1 (en) 2019-01-16
US20130230921A1 (en) 2013-09-05
ES2724198T3 (es) 2019-09-09
SG10201603901UA (en) 2016-07-28
EP2609194A4 (en) 2014-02-19
SG188306A1 (en) 2013-04-30
US9994821B2 (en) 2018-06-12
JP2013535975A (ja) 2013-09-19
WO2012024782A1 (en) 2012-03-01
EP2609194A1 (en) 2013-07-03
AU2011293052A1 (en) 2013-03-28
JP2018196399A (ja) 2018-12-13

Similar Documents

Publication Publication Date Title
DK2609194T3 (da) Fremgangsmåder til berigelse af pluripotente stamcelle-afledte kardiomyocyt-progenitorceller og kardiomyocytceller baseret på SIRPA-ekspression
DK2614141T3 (da) Hidtil ukendte fremgangsmåder og dyrkningsmedier til dyrkning af pluripotente stamceller
BRPI1011127A2 (pt) métodos para o cultivo de células tronco e células progenitoras
DK2855667T3 (da) Fremgangsmåder til manipulation af allogeniske og immunosuppressiv-resistante T-celler til immunterapi
FI20096288A0 (fi) Formulations and methods for culturing stem cells
DK2718422T3 (da) Dyrkningsmedier til stamceller
EP2692853A4 (en) MEMBRANE SEPARATION TYPE CULTURE DEVICE, MEMBRANE SEPARATION TYPE CULTURE KIT, METHOD FOR SEPARATING STEM CELLS EMPLOYING THE SAME, AND SEPARATION MEMBRANE
DK2836609T4 (da) Sammensætninger og fremgangsmåder til kvantificering af en nucleinsyresekvens i en prøve
DK3192865T3 (da) Enkelt pluripotent stamcelle-kultur
DK2574677T3 (da) Fremgangsmåder til celledyrkning
EP2966163A4 (en) CULTURE SYSTEM FOR PLURIPOTENT STEM CELLS AND METHOD FOR SUB-CULTURE OF PLURIPOTENT STEM CELLS
EP2811011A4 (en) CELL CULTURE KIT AND METHOD FOR USING THE CELL CULTURE KIT
DK3330370T3 (da) Fremgangsmåde til dyrkning af cho-celler
EP2784153A4 (en) METHOD FOR THE CULTURE OF PLURIPOTENT STEM CELLS
EP2671945A4 (en) METHOD OF BREEDING HUMAN PLURIPOTENTER STEM CELLS
DK2705143T3 (da) Protein-induceret pluripotent celleteknologi og anvendelse deraf
SG11201505965TA (en) Culture method for stable undifferentiated proliferation of pluripotent stem cells
DK3017038T3 (da) Differentiering af pluripotente stamceller og hjerteprogenitorceller i tværstribede kardiomyocytfibre under anvendelse af lamininer ln-511, ln-521 og ln-221
DK2756075T3 (da) Fremgangsmåde til fremstilling af inducerede paraksiale mesoderme progenitor (IPAM)-celler og anvendelse deraf
DK2672807T3 (da) Fremgangsmåde og bioreaktor til dyrkning af mikroorganismer
DK2658965T3 (da) Fremgangsmåde til fremstilling af inducerede pluripotente stamceller og differentierede celler
GB201117469D0 (en) Culture media for pluripotent stem cells
DK3064575T3 (da) Fremgangsmåde til differentiering af pluripotent stamcelle induceret fra mesenkymal stamcelle til hepatocyt
HK1196848A1 (zh) 適應於角質形成細胞的黑素細胞或其祖細胞、以及其製備方法
EP2949746A4 (en) METHOD OF SUB-CULTURE OF PLURIPOTENT STEM CELLS